Arrowstreet Capital, Limited Partnership Kamada LTD Transaction History
Arrowstreet Capital, Limited Partnership
- $148 Billion
- Q3 2025
A detailed history of Arrowstreet Capital, Limited Partnership transactions in Kamada LTD stock. As of the latest transaction made, Arrowstreet Capital, Limited Partnership holds 34,674 shares of KMDA stock, worth $243,758. This represents 0.0% of its overall portfolio holdings.
Number of Shares
34,674
Previous 60,558
42.74%
Holding current value
$243,758
Previous $469,000
49.04%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding KMDA
# of Institutions
48Shares Held
5.96MCall Options Held
0Put Options Held
0-
Phoenix Holdings Ltd. Givatayim, L31.65MShares$11.6 Million0.14% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny872KShares$6.13 Million0.01% of portfolio
-
Wells Fargo & Company San Francisco, CA606KShares$4.26 Million0.0% of portfolio
-
Essex Investment Management CO LLC Boston, MA396KShares$2.79 Million0.48% of portfolio
-
Acadian Asset Management LLC Boston, MA274KShares$1.93 Million0.0% of portfolio
About KAMADA LTD
- Ticker KMDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 44,800,500
- Market Cap $315M
- Description
- Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...